至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Ultrabright nanoparticle-labeled lateral flow immunoassay for detection of anti-SARS-CoV-2 neutralizing antibodies in human serum

Biomaterials. 2022-08; 
Lun Bian , Zhaoyue Li , An He , Biru Wu , Hui Yang , Yingsong Wu , Fang Hu , Guanfeng Lin , Deqing Zhang
Products/Services Used Details Operation
Recombinant Proteins SARS-CoV-2 nucleocapsid S RBD fusion and human ACE2 Fc chimera were purchased from GenScript Inc. (Piscataway, NJ, USA). Get A Quote

摘要

The level of anti-SARS-CoV-2 neutralizing antibodies (NAb) is an indispensable reference for evaluating the acquired protective immunity against SARS-CoV-2. Here, we established an ultrabright nanoparticles-based lateral flow immunoassay (LFIA) for one-step rapid semi-quantitative detection of anti-SARS-CoV-2 NAb in vaccinee's serum. Once embedded in polystyrene (PS) nanoparticles, the aggregation-induced emission (AIE) luminogen, AIE490, exhibited ultrabright fluorescence due to the rigidity of PS and severe inhibition of intramolecular motions. The ultrabright AIE490-PS nanoparticle was used as a fluorescent marker of LFIA. Upon optimized conditions including incubation time, concentrations of coated proteins... More

关键词

Aggregation-induced emission; Lateral flow immunoassay; Neutralizing antibody; SARS-CoV-2.